OME Group

Ome is a pioneering therapeutics holding company specializing in biotech innovations, including stem cell therapies and AI-designed precision medicine. The company leverages a proprietary platform that combines stem cell science, omics data, and AI-powered biological intelligence to accelerate the discovery and manufacturing of next-generation therapies. Ome's dual-use innovation strategy targets both civilian healthcare and military readiness, with a focus on trauma-ready biologics, battlefield diagnostics, and regenerative tools. By operating as a holding company, Ome identifies and accelerates high-potential platforms through a global network of public and private partnerships to maximize therapeutic impact and reduce time-to-market.